| Zackery David Nance, DPM | |
|
5050 Ne Hoyt St, Suite 428, Portland, OR 97213-2991 | |
| (503) 963-2964 | |
| (503) 963-2966 |
| Full Name | Zackery David Nance |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 13 Years |
| Location | 5050 Ne Hoyt St, Portland, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194012989 | NPI | - | NPPES |
| 500670855 | Medicaid | OR | |
| 1194012989 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | SC006300 (Pennsylvania) | Secondary |
| 213E00000X | Podiatrist | DP167551 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Portland Medical Center | Portland, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oregon Clinic Pc | 2860390408 | 319 |
News Archive
Merck on Tuesday agreed to a $58 million settlement with 29 states and the District of Columbia to end investigations over allegations that it downplayed cardiovascular risks caused by the COX-2 inhibitor Vioxx in direct-to-consumer advertisements dating back to 1999, the AP/Philadelphia Inquirer reports (Raffaele, AP/Philadelphia Inquirer, 5/21).
LifeVest, a technology being developed at St. Michael's Hospital to help newborns breathe, won the Global Healthcare Innovation Academy's international competition in Calgary.
A recent multicenter clinical trial of atorvastatin, a type of cholesterol-lowering drug, found that although the drug did not inhibit plasma HIV RNA levels, it did inhibit expression of cellular markers of immune activation and inflammation in patients with HIV infection.
Elekta has signed an agreement to sell its 49 percent stake in Motala Verkstad AB. The buyer is Qeep Group.
› Verified 3 days ago
| Provider Name | Oregon Clinic Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1265417174 PECOS PAC ID: 2860390408 Enrollment ID: O20031222000096 |
News Archive
Merck on Tuesday agreed to a $58 million settlement with 29 states and the District of Columbia to end investigations over allegations that it downplayed cardiovascular risks caused by the COX-2 inhibitor Vioxx in direct-to-consumer advertisements dating back to 1999, the AP/Philadelphia Inquirer reports (Raffaele, AP/Philadelphia Inquirer, 5/21).
LifeVest, a technology being developed at St. Michael's Hospital to help newborns breathe, won the Global Healthcare Innovation Academy's international competition in Calgary.
A recent multicenter clinical trial of atorvastatin, a type of cholesterol-lowering drug, found that although the drug did not inhibit plasma HIV RNA levels, it did inhibit expression of cellular markers of immune activation and inflammation in patients with HIV infection.
Elekta has signed an agreement to sell its 49 percent stake in Motala Verkstad AB. The buyer is Qeep Group.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Zackery David Nance, DPM 847 Ne 19th Ave, Suite 300, Portland, OR 97232-2684 Ph: (503) 963-2801 | Zackery David Nance, DPM 5050 Ne Hoyt St, Suite 428, Portland, OR 97213-2991 Ph: (503) 963-2964 |
News Archive
Merck on Tuesday agreed to a $58 million settlement with 29 states and the District of Columbia to end investigations over allegations that it downplayed cardiovascular risks caused by the COX-2 inhibitor Vioxx in direct-to-consumer advertisements dating back to 1999, the AP/Philadelphia Inquirer reports (Raffaele, AP/Philadelphia Inquirer, 5/21).
LifeVest, a technology being developed at St. Michael's Hospital to help newborns breathe, won the Global Healthcare Innovation Academy's international competition in Calgary.
A recent multicenter clinical trial of atorvastatin, a type of cholesterol-lowering drug, found that although the drug did not inhibit plasma HIV RNA levels, it did inhibit expression of cellular markers of immune activation and inflammation in patients with HIV infection.
Elekta has signed an agreement to sell its 49 percent stake in Motala Verkstad AB. The buyer is Qeep Group.
› Verified 3 days ago
Barnes Foot And Ankle Podiatrist Medicare: Medicare Enrolled Practice Location: 9615 Nw Randall Ln, Portland, OR 97229 Phone: 503-297-2222 | |
Edward Theodore Ysunza Iv, Podiatrist Medicare: Medicare Enrolled Practice Location: 3710 Sw Us Veterans Hospital Rd, Portland, OR 97239 Phone: 503-220-8262 | |
Dr. Brian M. Bowen, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1717 Ne 42nd Ave, Suite 3300, Portland, OR 97213 Phone: 503-284-2000 Fax: 503-284-2002 | |
Town Center Foot Clinic Podiatrist Medicare: Medicare Enrolled Practice Location: 8305 Se Monterey Ave Ste 101, Portland, OR 97266 Phone: 503-652-1121 Fax: 503-652-2193 | |
Ray A Mcclanahan, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 725 Nw 19th Ave, Portland, OR 97209 Phone: 503-243-2699 Fax: 503-243-2698 | |
Portland Foot And Ankle Institute, Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 12672 Nw Barnes Rd Ste 100, Portland, OR 97229 Phone: 503-336-0169 Fax: 503-352-4583 | |
Dr. Steven Gary Tillett, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 6274 Sw Capitol Hwy, Portland, OR 97239 Phone: 503-246-2212 |